Hologic (NASDAQ: HOLX) reported Q4 EPS of $0.52, $0.02 better than the analyst estimate of $0.50. Revenue for the quarter came in at $726.8 million versus the consensus estimate of $721.66 million.

GUIDANCE:

Hologic sees Q1 2017 EPS of $0.50-$0.51, versus the consensus of $0.51.

Hologic sees FY2017 EPS of $2.12-$2.16, versus the consensus of $2.13.

For earnings history and earnings-related data on Hologic (HOLX) click here.